| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |